IXOPAY & Riskified Announce Partnership to Boost Fraud Prevention and Enhance Enterprise Payment Orchestration
The partnership will help ecommerce customers securely expand their businesses by leveraging omnichannel payment orchestration with AI fraud detection
LEHI, UT and NEW YORK, NY / ACCESSWIRE / January 9, 2025 / IXOPAY, a leading enterprise payment orchestration platform, and Riskified (NYSE:RSKD), a leader in ecommerce fraud and risk intelligence, today announced a strategic partnership to enhance payment security, reduce fraud challenges and increase payment operation resilience. As global payment ecosystems become more complex, so do the associated risks. IXOPAY and Riskified are teaming up to provide businesses with a seamless, secure and efficient way to enhance their payments orchestration and effectively repel fraud threats.
IXOPAY + Riskified
IXOPAY and Riskified partnership
This partnership combines IXOPAY's payment orchestration, tokenization, and flexible payment optimization capabilities with Riskified's AI-powered fraud and risk intelligence platform. Businesses using this combined solution will have the opportunity to increase sales conversion by reducing false declines, enhance security to minimize fraud chargebacks, and optimize payment flows for a frictionless customer payment experience-enabling merchant growth while minimizing risk.
"IXOPAY's mission to deliver a comprehensive, secure payment orchestration platform is advanced by our exciting partnership with Riskified," said Brady Harris, CEO of IXOPAY. "Riskified's machine learning technology enhances our ability to detect fraud and reduce chargebacks, further strengthening our commitment to safeguarding revenue while approving more legitimate transactions."
"Our partnership with IXOPAY marks a significant step forward in helping merchants optimize their payment processes and improve operational efficiency," said Eido Gal, CEO of Riskified. "By integrating omnichannel payment processing, we're strengthening our fraud prevention capabilities while improving the transaction experience for merchants and consumers."
"The partnership between IXOPAY and Riskified will provide Super.com a market advantage with end customers and travel agency partners," said Sarah Boehmer, Senior Director of Payment Processing & Fraud Strategy at Super.com. "The unified solution will allow us to collect a credit card PAN and securely forward it to our travel partners, while keeping Super.com PCI compliant and our customers protected from fraud."
Designed to enhance payment processing by integrating AI-powered fraud detection, IXOPAY and Riskified's partnership will reduce operational costs by minimizing the need for manual reviews and improve customer satisfaction by decreasing false declines and other transaction disruptions. The combined solution will help ensure regulation compliance, provide real-time threat response, and improve adaptive payment routing while providing robust network-wide analytics to improve overall ecommerce performance.
To learn more about the evolving world of ecommerce orchestration, request an invitation to join Riskified and IXOPAY's January 11 networking reception in New York City on the eve of NRF 2025 and visit Riskified's NRF booth (3675) January 12-14.
Additional details on the partnership are available at https://go.ixopay.com/partner/riskified.
IXOPAY Media Contact:
Mills Forni
mills@verdis.xyz
Riskified Media Contact:
Ciara DiVita
riskified@5wpr.com
About IXOPAY
IXOPAY is a leading provider of enterprise-grade payment orchestration, providing a fully integrated platform and flexible payment optimization modules to businesses around the world. With a single API and scalable payments architecture, IXOPAY empowers businesses to simplify, secure, and increase the resilience of their payment systems. Learn more at www.ixopay.com and follow us on LinkedIn.
About Riskified
Riskified (NYSE:RSKD) empowers businesses to unleash ecommerce growth by outsmarting risk. Many of the world's biggest brands and publicly traded companies selling online rely on Riskified for guaranteed protection against chargebacks, to fight fraud and policy abuse at scale, and to improve customer retention. Developed and managed by the largest team of ecommerce risk analysts, data scientists, and researchers, Riskified's AI-powered fraud and risk intelligence platform analyzes the individual behind each interaction to provide real-time decisions and robust identity-based insights. Riskified was named to CNBC's World's Top Fintech Companies in 2024. Learn more at riskified.com.
SOURCE: IXOPAY & Riskified
View the original press release on accesswire.com
IXOPAY & Riskified
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom